{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:46:18Z","timestamp":1792183578163,"version":"4.4.0"},"reference-count":40,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":132,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Guideline-based lobectomy criteria were adopted in July 2017, and reflexive molecular testing (MT) was introduced for all Bethesda III\/IV indeterminate thyroid nodules (ITNs) in July 2020. This study evaluates how reflexive MT of ITNs influenced lobectomy and completion thyroidectomy (CT) rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with well-differentiated thyroid cancer who had undergone surgery were identified from a prospective database. Patients were categorized into three groups: i) Bethesda V\/VI initial lobectomy, ii) Bethesda III\/IV initial lobectomy without MT, iii) Bethesda III\/IV lobectomy candidates with MT. The indications for and rates of lobectomy and CT, postoperative complications, and thyroid hormone replacement (THR) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From July 2017 to October 2023, 227 of 799 (28%) patients with thyroid cancer underwent initial lobectomy, with 91, 70, and 64 patients in each group, respectively. Included in group 3 were 16 ITNs that would have undergone diagnostic lobectomy; however, due to the presence of a malignant mutation, they underwent total thyroidectomy (TT). TT was the appropriate surgery for 15 of 16 patients based on either preoperative lobectomy exclusion criteria or final pathology. CT rates by group were 26, 43, and 27%, respectively (P &amp;lt; 0.05). Vascular invasion, tumor size &amp;gt;4 cm, and aggressive histology were the most common indications for CT. ThyroSPEC was independently associated with a lower likelihood of CT in multivariate analysis. Surgical complications were lower with lobectomy (2%) versus CT (7%), with 44% of lobectomy patients requiring THR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Reflexive MT for ITNs decreased CT rates by increasing appropriate upfront TT. Lobectomy demonstrated lower rates of surgical complications and THR than two-stage thyroidectomy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0189","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:03:51Z","timestamp":1772031831000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":2,"title":["Impact of reflexive preoperative molecular testing for indeterminate nodules on lobectomy and completion thyroidectomy rates"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-0910","authenticated-orcid":true,"given":"Caitlin T","family":"Yeo","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6989-0759","authenticated-orcid":true,"given":"Jiahui","family":"Wu","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Ghaznavi","sequence":"additional","affiliation":[{"name":"2"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Stewardson","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Amanullah","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Box","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4732-2934","authenticated-orcid":true,"given":"Markus","family":"Eszlinger","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1470-268X","authenticated-orcid":true,"given":"Ralf","family":"Paschke","sequence":"additional","affiliation":[{"name":"2"},{"name":"4"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"2026070714020094100_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070714020094100_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jss.2019.04.036","article-title":"Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review","volume":"242","author":"Vargas-Pinto","year":"2019","journal-title":"J Surg Res"},{"key":"2026070714020094100_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamasurg.2021.6442","article-title":"Association of total thyroidectomy or thyroid lobectomy with the quality of life in patients with differentiated thyroid cancer with low to intermediate risk of recurrence","volume":"157","author":"Chen","year":"2022","journal-title":"JAMA Surg"},{"key":"2026070714020094100_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.surg.2019.01.007","article-title":"Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years","volume":"166","author":"James","year":"2019","journal-title":"Surgery"},{"key":"2026070714020094100_bib5","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1245\/s10434-021-09898-9","article-title":"Thyroid lobectomy for low-risk papillary thyroid cancer: a national survey of low-and high-volume surgeons","volume":"28","author":"McDow","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026070714020094100_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/thy.2010.0243","article-title":"A large multicenter correlation study of thyroid nodule cytopathology and histopathology","volume":"21","author":"Wang","year":"2011","journal-title":"Thyroid"},{"key":"2026070714020094100_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339959","article-title":"The Bethesda system for reporting thyroid cytopathology: a meta-analysis","volume":"56","author":"Bongiovanni","year":"2012","journal-title":"Acta Cytol"},{"key":"2026070714020094100_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4158\/EP161540.OR","article-title":"Gauging the extent of thyroidectomy for indeterminate thyroid nodules: an oncologic perspective","volume":"23","author":"Schneider","year":"2017","journal-title":"Endocr Pract"},{"key":"2026070714020094100_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00268-019-05189-3","article-title":"Need for completion thyroidectomy in patients undergoing lobectomy for indeterminate and high-risk nodules: impact of intra-operative findings and final pathology","volume":"44","author":"Moore","year":"2020","journal-title":"World J Surg"},{"key":"2026070714020094100_bib10","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.30708","article-title":"Molecular testing for thyroid nodules: review and current state","volume":"124","author":"Roth","year":"2018","journal-title":"Cancer"},{"key":"2026070714020094100_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/SLA.0000000000000215","article-title":"A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy","volume":"260","author":"Yip","year":"2014","journal-title":"Ann Surg"},{"key":"2026070714020094100_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaoto.2023.1494","article-title":"Prognostic value of preoperative molecular testing and implications for initial surgical management in thyroid nodules harboring suspected (Bethesda V) or known (Bethesda VI) papillary thyroid cancer","volume":"149","author":"Schumm","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070714020094100_bib13","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/thy.2018.0779","article-title":"Molecular testing versus diagnostic lobectomy in Bethesda III\/IV thyroid nodules: a cost-effectiveness analysis","volume":"29","author":"Nicholson","year":"2019","journal-title":"Thyroid"},{"key":"2026070714020094100_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40463-022-00604-7","article-title":"Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules","volume":"51","author":"Dharampal","year":"2022","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2026070714020094100_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/thy.2023.0255","article-title":"Prospective validation of ThyroSPEC molecular testing of indeterminate thyroid nodule cytology following diagnostic pathway optimization","volume":"33","author":"Stewardson","year":"2023","journal-title":"Thyroid"},{"key":"2026070714020094100_bib16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/thy.2024.0481","article-title":"Development of a nomogram to integrate molecular testing and clinical variables to improve malignancy risk assessment among cytologically indeterminate thyroid nodules","volume":"35","author":"Wu","year":"2025","journal-title":"Thyroid"},{"key":"2026070714020094100_bib17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1089\/thy.2022.0055","article-title":"The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a Canadian tertiary care referral setting","volume":"32","author":"Wu","year":"2022","journal-title":"Thyroid"},{"key":"2026070714020094100_bib18","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"2026070714020094100_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jasc.2025.04.003","article-title":"Performance characteristics of ThyroSeq, ThyGeNEXT\/ThyraMIR, and Afirma molecular platforms in evaluation of 1252 cytologically-indeterminate thyroid nodules","volume":"14","author":"Connelly","year":"2025","journal-title":"J Am Soc Cytopathol"},{"key":"2026070714020094100_bib20","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1210\/clinem\/dgad220","article-title":"Molecular profiling of 50 734 Bethesda III\u2013VI thyroid nodules by ThyroSeq v3: implications for personalized management","volume":"108","author":"Chiosea","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070714020094100_bib21","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.surg.2013.06.031","article-title":"Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of \u201csuspicious for papillary thyroid cancer.\u201d","volume":"154","author":"Leiker","year":"2013","journal-title":"Surgery"},{"key":"2026070714020094100_bib22","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1245\/s10434-016-5280-6","article-title":"Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk features","volume":"23","author":"Lang","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2026070714020094100_bib23","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/lary.28634","article-title":"Total thyroidectomy versus lobectomy in small nodules suspicious for papillary thyroid cancer: cost-effectiveness analysis","volume":"130","author":"Al-Qurayshi","year":"2020","journal-title":"Laryngoscope"},{"key":"2026070714020094100_bib24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/thy.2019.0274","article-title":"The identification of intraoperative risk factors can reduce, but not exclude, the need for completion thyroidectomy in low-risk papillary thyroid cancer patients","volume":"30","author":"Craig","year":"2020","journal-title":"Thyroid"},{"key":"2026070714020094100_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.surg.2017.04.029","article-title":"Correct extent of thyroidectomy is poorly predicted preoperatively by the guidelines of the American Thyroid Association for low and intermediate risk thyroid cancers","volume":"163","author":"Dhir","year":"2018","journal-title":"Surgery"},{"key":"2026070714020094100_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/bjs5.50137","article-title":"Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy","volume":"3","author":"DiMarco","year":"2019","journal-title":"BJS Open"},{"key":"2026070714020094100_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejso.2019.10.004","article-title":"Quantifying the differences in surgical management of patients with definitive and indeterminate thyroid nodule cytology","volume":"46","author":"Stewart","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2026070714020094100_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/cncr.21055","article-title":"The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma","volume":"103","author":"Machens","year":"2005","journal-title":"Cancer"},{"key":"2026070714020094100_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-86611-6","article-title":"The role of the size in thyroid cancer risk stratification","volume":"11","author":"Vianello","year":"2021","journal-title":"Sci Rep"},{"key":"2026070714020094100_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.06.066","article-title":"Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence","volume":"177","author":"Kurtom","year":"2025","journal-title":"Surgery"},{"key":"2026070714020094100_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamaoto.2022.0621","article-title":"Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: a systematic review and meta-analysis","volume":"148","author":"Hsiao","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026070714020094100_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X21992001","article-title":"Prediction of thyroid hormone replacement following thyroid lobectomy: a long-term retrospective study","volume":"5","author":"Meyer","year":"2021","journal-title":"OTO Open"},{"key":"2026070714020094100_bib33","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.amjsurg.2020.06.052","article-title":"Postoperative thyroid hormone supplementation rates following thyroid lobectomy","volume":"220","author":"Wilson","year":"2020","journal-title":"Am J Surg"},{"key":"2026070714020094100_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.eprac.2021.01.004","article-title":"Frequency of thyroid hormone replacement after lobectomy for differentiated thyroid cancer","volume":"27","author":"Schumm","year":"2021","journal-title":"Endocr Pract"},{"key":"2026070714020094100_bib35","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/cancers14102472","article-title":"Risk of complications in patients undergoing completion thyroidectomy after hemithyroidectomy for thyroid nodule with indeterminate cytology: an Italian multicentre retrospective study","volume":"14","author":"Canu","year":"2022","journal-title":"Cancers"},{"key":"2026070714020094100_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0194599820951165","article-title":"A national comparison of postoperative outcomes in completion thyroidectomy and total thyroidectomy","volume":"164","author":"Brauer","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"2026070714020094100_bib37","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jso.26044","article-title":"Outcomes after completion thyroidectomy versus total thyroidectomy for differentiated thyroid cancer: a single-center experience","volume":"122","author":"Dedhia","year":"2020","journal-title":"J Surg Oncol"},{"key":"2026070714020094100_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"2026070714020094100_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00268-013-2224-1","article-title":"Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases","volume":"38","author":"Matsuzu","year":"2014","journal-title":"World J Surg"},{"key":"2026070714020094100_bib40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","article-title":"Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients","volume":"260","author":"Adam","year":"2014","journal-title":"Ann Surg"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/15\/2\/ETJ-25-0189.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/15\/2\/ETJ-25-0189.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0189\/503539\/etj-25-0189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0189\/503539\/etj-25-0189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:02:14Z","timestamp":1783447334000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/15\/2\/ETJ250189\/75675\/Impact-of-reflexive-preoperative-molecular-testing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0189","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"ETJ250189"}}